Samar A. Antar

1.3k total citations · 2 hit papers
25 papers, 816 citations indexed

About

Samar A. Antar is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Samar A. Antar has authored 25 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Samar A. Antar's work include Chemotherapy-induced organ toxicity mitigation (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Samar A. Antar is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Samar A. Antar collaborates with scholars based in Egypt, United States and Saudi Arabia. Samar A. Antar's co-authors include Ahmed A. Al‐Karmalawy, Nada A. Ashour, Mohamed A. Saleh, Ahmed Elkamhawy, Marwa Sharaky, Muhammad Khattab, Eun Joo Roh, Mona F. El-Azab, Walied Abdo and Ayman M. Mahmoud and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

Samar A. Antar

24 papers receiving 803 citations

Hit Papers

Diabetes mellitus: Classification, mediators, and complic... 2023 2026 2024 2025 2023 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
    2023 214 citations Samar A. Antar, Nada A. Ashour et al. Biomedicine & Pharmacotherapy profile →
  2. Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
    2023 167 citations Samar A. Antar, Nada A. Ashour et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar A. Antar Egypt 14 264 120 91 83 82 25 816
Yüksel Aliyazıcıoğlu Türkiye 22 440 1.7× 103 0.9× 59 0.6× 72 0.9× 52 0.6× 99 1.4k
Krisztina Hagymási Hungary 17 233 0.9× 105 0.9× 97 1.1× 153 1.8× 120 1.5× 89 922
Yiyi Jin China 16 353 1.3× 66 0.6× 74 0.8× 47 0.6× 54 0.7× 31 747
Yiwei Li China 17 457 1.7× 105 0.9× 60 0.7× 92 1.1× 118 1.4× 35 1.1k
Mohamed A. Kandeil Egypt 16 304 1.2× 67 0.6× 71 0.8× 44 0.5× 127 1.5× 44 872
Wenbo Ding China 13 422 1.6× 106 0.9× 37 0.4× 97 1.2× 91 1.1× 42 860
Gang Luo China 17 468 1.8× 113 0.9× 59 0.6× 63 0.8× 63 0.8× 60 1.3k
Joanne M. Dennis Australia 14 267 1.0× 50 0.4× 46 0.5× 83 1.0× 56 0.7× 22 816
Haiyan Xu China 21 531 2.0× 80 0.7× 93 1.0× 109 1.3× 94 1.1× 105 1.3k
Ming‐Shun Wu Taiwan 18 379 1.4× 57 0.5× 70 0.8× 115 1.4× 128 1.6× 47 1.1k

Countries citing papers authored by Samar A. Antar

Since Specialization
Citations

This map shows the geographic impact of Samar A. Antar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar A. Antar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar A. Antar more than expected).

Fields of papers citing papers by Samar A. Antar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar A. Antar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar A. Antar. The network helps show where Samar A. Antar may publish in the future.

Co-authorship network of co-authors of Samar A. Antar

This figure shows the co-authorship network connecting the top 25 collaborators of Samar A. Antar. A scholar is included among the top collaborators of Samar A. Antar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar A. Antar. Samar A. Antar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antar, Samar A., Maisa Siddiq Abduh, Mousa O. Germoush, et al.. (2024). Coenzyme Q10 mitigates cadmium cardiotoxicity by downregulating NF-κB/NLRP3 inflammasome axis and attenuating oxidative stress in mice. Life Sciences. 348. 122688–122688. 12 indexed citations
2.
Antar, Samar A., et al.. (2023). Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. International Journal of Molecular Sciences. 24(4). 4004–4004. 167 indexed citations breakdown →
3.
Antar, Samar A., Ahmed Abdeen, Mohamed Abdo, et al.. (2023). Modulatory Role of Autophagy in Metformin Therapeutic Activity toward Doxorubicin-Induced Nephrotoxicity. Toxics. 11(3). 273–273. 7 indexed citations
4.
Abdo, Walied, Amira Osman, Ahmad Alsulimani, et al.. (2023). Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats. Life Sciences. 322. 121688–121688. 17 indexed citations
5.
Al‐Karmalawy, Ahmed A., et al.. (2023). Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice. Life Sciences. 316. 121390–121390. 31 indexed citations
6.
Antar, Samar A., Nada A. Ashour, Marwa Sharaky, et al.. (2023). Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharmacotherapy. 168. 115734–115734. 214 indexed citations breakdown →
7.
Antar, Samar A., et al.. (2023). An Overview of the Mechanisms of Cadmium-induced Toxicity in the Male Reproductive System. Pharmaceutical Sciences. 30(1). 36–53. 4 indexed citations
8.
Antar, Samar A., et al.. (2023). A Comprehensive Overview of Organ Inflammatory Responses: Genesis, Possible Mechanisms, and Mediators of Inflammation. Pharmaceutical Sciences. 29(4). 397–416. 4 indexed citations
9.
10.
Antar, Samar A., Mohamed A. Saleh, & Ahmed A. Al‐Karmalawy. (2022). Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2. Life Sciences. 309. 121048–121048. 38 indexed citations
11.
12.
Al‐Karmalawy, Ahmed A., Mohamed S. Nafie, Moataz A. Shaldam, et al.. (2022). Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. Journal of Medicinal Chemistry. 66(1). 777–792. 45 indexed citations
13.
Antar, Samar A., et al.. (2022). Etanercept Mitigates Cadmium Chloride-induced Testicular Damage in Rats "An Insight into Autophagy, Apoptosis, Oxidative Stress and Inflammation". Environmental Science and Pollution Research. 29(19). 28194–28207. 17 indexed citations
14.
Saleh, Mohamed A., et al.. (2022). Genistin modulates high-mobility group box protein 1 (HMGB1) and nuclear factor kappa-B (NF-κB) in Ehrlich-ascites-carcinoma-bearing mice. Environmental Science and Pollution Research. 30(1). 966–978. 8 indexed citations
15.
16.
17.
18.
Antar, Samar A., et al.. (2021). A novel role of pirfenidone in attenuation acetic acid induced ulcerative colitis by modulation of TGF-β1 / JNK1 pathway. International Immunopharmacology. 101(Pt B). 108289–108289. 11 indexed citations
19.
Antar, Samar A., et al.. (2021). Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor. Life Sciences. 288. 120185–120185. 36 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yüksel Aliyazıcıoğlu Breakdown of academic impact, for papers by Krisztina Hagymási Breakdown of academic impact, for papers by Yiyi Jin Breakdown of academic impact, for papers by Yiwei Li Breakdown of academic impact, for papers by Mohamed A. Kandeil Breakdown of academic impact, for papers by Wenbo Ding Breakdown of academic impact, for papers by Gang Luo Breakdown of academic impact, for papers by Joanne M. Dennis Breakdown of academic impact, for papers by Haiyan Xu Breakdown of academic impact, for papers by Ming‐Shun Wu
Rankless by CCL
2026